Keun-Wook Lee

Seoul National University Hospital

South Korea

Research Interests

Explore related searches

Professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (8)

Samuel Klempner

Associate Professor

Massachusetts General Hospital

UNITED STATES

View details

Yung-Jue Bang

Professor

Seoul National University College of Medicine

SOUTH KOREA

View details

Seong Gu Heo

Dana-Farber Cancer Institute

UNITED STATES

View details

Ji Eun Kim

Seoul National University College of Medicine

SOUTH KOREA

View details

Jin Won Kim

Professor

Seoul National University Hospital

SOUTH KOREA

View details

Rom Leidner

UNITED STATES

View details

Sung-Bum Kang

Seoul National University Hospital

SOUTH KOREA

View details

Woong-Yang Park

Professor

Sungkyunkwan University

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Keun-Wook Lee

Research Interests

Explore related searches

Contact this professor

Articles (10)

Liquid Biopsy: An Emerging Diagnostic, Prognostic, and Predictive Tool in Gastric Cancer

Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH Trial

ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2–Positive Gastric or Gastroesophageal Junction Adenocarcinoma

A Phase II Study of Nivolumab plus Gemcitabine in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma (KCSG HN17–11)

Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Association of Tumor Mutational Burden with Efficacy of Pembrolizumab±Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study

Effectiveness of oral fluoropyrimidine monotherapy as adjuvant chemotherapy for high-risk stage II colon cancer

Randomized Phase II Study of Axitinib versus Observation in Patients with Recurred or Metastatic Adenoid Cystic Carcinoma

Effectiveness of Combining Bevacizumab With First-Line Chemotherapy Regimens for Metastatic Colorectal Cancer in Real-World Practice

Safety and efficacy of durvalumab and tremelimumab alone or in combination in patients with advanced gastric and gastroesophageal junction adenocarcinoma

Collaborators (8)

Samuel Klempner

Yung-Jue Bang

Seong Gu Heo

Ji Eun Kim

Jin Won Kim

Rom Leidner

Sung-Bum Kang

Woong-Yang Park

Make your next move.